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Cardiac amyloidosis is rare, but when diagnosed it has an urgent and speciﬁc treatment.
Two patients with similar concentric left ventricular hypertrophy on echocardiography
were investigated with cardiac magnetic resonance (CMR) to differentiate cardiac amyloi-
dosis from hypertrophic cardiomyopathy.
In the setting of hypertrophic cardiomyopathy, early hyperenhancement occurs around
200ms, comparable to normal (Fig. 1, arrows in top and middle rows). Late myocardium
enhancement is characterized by multiple non-speciﬁc interstitial nodules within the
hypertrophic myocardium suggesting interstitial ﬁbrosis. When a diagnosis of cardiac amy-
loidosis is established, CMR demonstrates late subendocardial enhancement on delayed
images associated with a short inversion time, around 150ms (Fig. 1, arrow in bottom
row).
The inversion time is assessed according to the TI scouting technique (Look Locker
sequence), which estimates the normal myocardial T1 relaxation time. Brieﬂy, 10 tohypertrophique
primitive ;
IRM ;
Échocardiographie
15minutes after gadolinium injection, the same short-axis T1-weighted sequence is
acquired sequentially, typically around 50ms. The inversion time is chosen visually when
the myocardium turns black. It is dependent on the dose of gadolinium injected, the
time elapsed between gadolinium injection and imaging, and the patient. The normal
inversion time ranges from 250 to 300ms, and normally shortens in patients with cardiac
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figure 1. CMR short axis view at papillary muscle level showing s
CM: hypertrophic cardiomyopathy.
myloidosis, which is not observed with the other types of
eft ventricular hypertrophy.CMR could therefore be a non-invasive alternative to
yocardial biopsy to diagnose cardiac amyloidosis, with
sensitivity of 100% when the analysis is combined with
n electrocardiogram and echocardiography. Moreover, in
myloidosis, CMR is useful for following up patients (T1
C
Nned inversion-time in cardiac amyloidosis.
orrelates with left ventricular mass, thickness and systolic
unction) and to evaluate the response to chemotherapy.onﬂicts of interest and disclosures
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